Bio-Rad Laboratories (BIO) Short-Term Debt repayments (2009 - 2013)
Bio-Rad Laboratories (BIO) reported Short-Term Debt repayments of $1000.0 for Q2 2013, down 98.85% year-over-year from $87000.0 in Q2 2012, and up 105.26% on a QoQ basis from -$19000.0 in Q1 2013.
Bio-Rad Laboratories (BIO) has 5 years of Short-Term Debt repayments data on file, last reported at $1000.0 in Q2 2013.
- Quarterly Short-Term Debt repayments fell 98.85% year-over-year to $1000.0 in Q2 2013, while the trailing twelve-month figure through Jun 2013 was -$435000.0 (up 89.57% YoY) and the FY2012 annual result came in at -$191000.0, up 95.1% from the prior year.
- Short-Term Debt repayments climbed to $1000.0 in Q2 2013 per BIO's latest filing, from -$19000.0 in the prior quarter.
- Across five years, Short-Term Debt repayments topped out at $4.9 million in Q4 2009 and bottomed at -$3.9 million in Q4 2011.
- The 5-year median for Short-Term Debt repayments is -$9000.0 (2013), against an average of -$25500.0.
- Peak annual rise in Short-Term Debt repayments reached 289.59% in 2011, while the deepest fall reached 4169.23% in 2011.
- Tracing BIO's Short-Term Debt repayments over 5 years: stood at $4.9 million in 2009, then tumbled by 126.13% to -$1.3 million in 2010, then slumped by 199.46% to -$3.9 million in 2011, then jumped by 100.57% to $22000.0 in 2012, then sank by 95.45% to $1000.0 in 2013.
- Per Business Quant, the three latest BIO Short-Term Debt repayments figures stand at $1000.0 (Q2 2013), -$19000.0 (Q1 2013), and $22000.0 (Q4 2012).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 259.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 1,000.00 |
| Jun 30, 2013 | 1,000.00 |
| Mar 31, 2013 | -19,000.00 |
| Mar 31, 2013 | -19,000.00 |
| Dec 31, 2012 | 22,000.00 |
| Dec 31, 2012 | 22,000.00 |
| Sep 30, 2012 | -439,000.00 |
| Sep 30, 2012 | -439,000.00 |
| Jun 30, 2012 | 87,000.00 |
| Jun 30, 2012 | 87,000.00 |
| Mar 31, 2012 | 139,000.00 |
| Mar 31, 2012 | 139,000.00 |
| Dec 31, 2011 | -3.87 Mn |
| Dec 31, 2011 | -3.87 Mn |
| Sep 30, 2011 | -529,000.00 |
| Sep 30, 2011 | -529,000.00 |
| Jun 30, 2011 | 2.88 Mn |
| Jun 30, 2011 | 2.88 Mn |
| Mar 31, 2011 | -2.39 Mn |
| Mar 31, 2011 | -2.39 Mn |
| Dec 31, 2010 | -1.29 Mn |
| Dec 31, 2010 | -1.29 Mn |
| Sep 30, 2010 | 13,000.00 |
| Sep 30, 2010 | 13,000.00 |
| Jun 30, 2010 | 740,000.00 |
| Jun 30, 2010 | 740,000.00 |
| Mar 31, 2010 | -291,000.00 |
| Mar 31, 2010 | -291,000.00 |
| Dec 31, 2009 | 4.94 Mn |
| Dec 31, 2009 | 4.94 Mn |
| Sep 30, 2009 | -413,000.00 |
| Sep 30, 2009 | -413,000.00 |